These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 9036506)
1. [Paraneoplastic superior vena cava thrombosis disclosing an ovarian tumor]. Padovani M; Tillie-Leblond I; Vennin P; Demarcq G; Wallaert B Rev Mal Respir; 1996 Dec; 13(6):598-600. PubMed ID: 9036506 [TBL] [Abstract][Full Text] [Related]
2. [A case of advanced ovarian clear cell adenocarcinoma responding to cisplatin-cyclophosphamide and paclitaxel-carboplatin]. Iwasaki K; Komuro Y; Masumoto N; Asaoka K; Ishitani K Gan To Kagaku Ryoho; 1999 Sep; 26(10):1483-6. PubMed ID: 10500539 [TBL] [Abstract][Full Text] [Related]
3. [Superior vena cava syndrome--surgical solution--case report]. Galie N; Vasile R; Savu C; Petreanu C; Grigorie V; Tabacu E Chirurgia (Bucur); 2010; 105(6):835-8. PubMed ID: 21355182 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of the combination paclitaxel/carboplatin in patients with previously treated advanced ovarian carcinoma: a multicenter French Groupe des Investigateurs Nationaux pour l'Etude des Cancers Ovariens phase II study. Pujade-Lauraine E; Guastalla JP; Weber B; Curé H; Orfeuvre H; Mousseau M; Vincent P; Diéras V; Tubiana-Mathieu N; Jacquin JP; Mignot L; Leduc B; Paraïso D; Viens P Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-30-S15-35. PubMed ID: 9346219 [TBL] [Abstract][Full Text] [Related]
5. Recent advances in the management of women with ovarian cancer. Eltabbakh GH Minerva Ginecol; 2004 Feb; 56(1):81-9. PubMed ID: 14973412 [TBL] [Abstract][Full Text] [Related]
6. Phase I trial of carboplatin, paclitaxel, etoposide, and cyclophosphamide with granulocyte colony stimulating factor as first-line therapy for patients with advanced epithelial ovarian cancer. Tung N; Berkowitz R; Matulonis U; Quartulli M; Seiden M; Kim Y; Niloff J; Cannistra SA Gynecol Oncol; 2000 May; 77(2):271-7. PubMed ID: 10785477 [TBL] [Abstract][Full Text] [Related]
7. Response to salvage treatment in recurrent ovarian cancer treated initially with paclitaxel and platinum-based combination regimens. Roland PY; Barnes MN; Niwas S; Robertson MW; Alvarez R; Austin JM; Kilgore LC; Partridge EE Gynecol Oncol; 1998 Feb; 68(2):178-82. PubMed ID: 9514799 [TBL] [Abstract][Full Text] [Related]
8. ICON 2 and ICON 3 data in previously untreated ovarian cancer: results to date. Harper P Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-23-S15-25. PubMed ID: 9346217 [TBL] [Abstract][Full Text] [Related]
9. [Palliation for a recurrent lung cancer patient with superior vena cava syndrome by arterial infusion of CDDP through the implantable port system--a case report]. Taira N; Shinozaki Y; Kawai T; Miyake T; Hara F; Nakajima T Gan To Kagaku Ryoho; 1999 Mar; 26(4):531-3. PubMed ID: 10097752 [TBL] [Abstract][Full Text] [Related]
10. [Superior vena cava thrombosis in a patient on hemodialysis]. Saval N; Pou M; López Pedret J; Burrell M; Cases A Nefrologia; 2004; 24 Suppl 3():35-8. PubMed ID: 15219066 [TBL] [Abstract][Full Text] [Related]
11. Treatment of superior vena cava (SVC) syndrome and inferior vena cava (IVC) thrombosis in a patient with colorectal cancer: combination of SVC stenting and IVC filter placement to palliate symptoms and pave the way for port implantation. Sauter A; Triller J; Schmidt F; Kickuth R Cardiovasc Intervent Radiol; 2008 Jul; 31 Suppl 2():S144-8. PubMed ID: 17605068 [TBL] [Abstract][Full Text] [Related]
12. Paclitaxel with carboplatin versus paclitaxel with carboplatin alternating with cisplatin as first-line chemotherapy in advanced epithelial ovarian cancer: preliminary results of a Hellenic Cooperative Oncology Group study. Skarlos DV; Aravantinos G; Kosmidis P; Athanassiadis A; Stathopoulos GP; Pavlidis N; Bafaloukos D; Karphathios S; Papakostas P; Bamia C; Fountzilas G Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-57-S15-61. PubMed ID: 9346224 [TBL] [Abstract][Full Text] [Related]
13. A case of paraneoplastic nephrotic syndrome in a patient with ovarian carcinoma. Kim YT; Rha SY; Shim CY; Sohn JH; Kim C; Yu NC; Chung HC; Kim JH; Han DS; Kim BS; Roh JK Yonsei Med J; 2003 Jun; 44(3):539-43. PubMed ID: 12833596 [TBL] [Abstract][Full Text] [Related]
14. Epithelial ovarian cancer treated by platinum or platinum analogue with cyclophosphamide: experience in Ramathibodi Hospital. Linasmita V; Wilailak S; Srisupundit S; Tangtrakul S; Bullangpoti S; Israngura N J Med Assoc Thai; 1998 Jan; 81(1):10-6. PubMed ID: 9470316 [TBL] [Abstract][Full Text] [Related]
15. Carboplatin plus paclitaxel in the treatment of gynecologic malignancies: the Cleveland Clinic experience. Markman M; Kennedy A; Webster K; Kulp B; Peterson G; Belinson J Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-26-S15-29. PubMed ID: 9346218 [TBL] [Abstract][Full Text] [Related]
16. Cyclophosphamide "metronomic" chemotherapy for palliative treatment of a young patient with advanced epithelial ovarian cancer. Samaritani R; Corrado G; Vizza E; Sbiroli C BMC Cancer; 2007 Apr; 7():65. PubMed ID: 17433113 [TBL] [Abstract][Full Text] [Related]
17. The efficacy of adjuvant platinum-based chemotherapy in Stage I uterine papillary serous carcinoma (UPSC). Dietrich CS; Modesitt SC; DePriest PD; Ueland FR; Wilder J; Reedy MB; Pavlik EJ; Kryscio R; Cibull M; Giesler J; Manahan K; Huh W; Cohn D; Powell M; Slomovitz B; Higgins RV; Merritt W; Hunter J; Puls L; Gehrig P; van Nagell JR Gynecol Oncol; 2005 Dec; 99(3):557-63. PubMed ID: 16154185 [TBL] [Abstract][Full Text] [Related]
18. Clinical manifestations and associated disease syndromes in dogs with cranial vena cava thrombosis: 17 cases (1989-1996). Palmer KG; King LG; Van Winkle TJ J Am Vet Med Assoc; 1998 Jul; 213(2):220-4. PubMed ID: 9676591 [TBL] [Abstract][Full Text] [Related]
19. [Vena cava thrombosis in Behçet's disease. Analysis of a series of 10 cases]. Houman H; Lamloum M; Ben Ghorbel I; Khiari-Ben Salah I; Miled M Ann Med Interne (Paris); 1999 Dec; 150(8):587-90. PubMed ID: 10686638 [TBL] [Abstract][Full Text] [Related]
20. Carboplatin/paclitaxel versus cisplatin/paclitaxel as first-line chemotherapy in advanced ovarian cancer: an interim analysis of a randomized phase III trial of the Arbeitsgemeinschaft Gynäkologische Onkologie Ovarian Cancer Study Group. du Bois A; Lück HJ; Meier W; Möbus V; Costa S; Richter B; Warm M; Bauknecht T; Schröder W; Olbricht S; Nitz U; Jackisch C Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-44-S15-52. PubMed ID: 9346222 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]